These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2851184

  • 1. The present status of rotavirus vaccine development.
    Bishop R.
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):429-35. PubMed ID: 2851184
    [Abstract] [Full Text] [Related]

  • 2. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T.
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185
    [Abstract] [Full Text] [Related]

  • 3. [Rotavirus infections and their prevention with vaccines in children].
    Chippaux-Hyppolite C, Loukou Yao G, Chippaux A.
    Bull Soc Pathol Exot; 1991 Sep; 84(5 Pt 5):918-25. PubMed ID: 1668070
    [Abstract] [Full Text] [Related]

  • 4. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML.
    Rev Infect Dis; 1989 Sep; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [Abstract] [Full Text] [Related]

  • 5. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM.
    Vaccine; 2006 May 29; 24(22):4821-9. PubMed ID: 16621194
    [Abstract] [Full Text] [Related]

  • 6. [Rotaviruses in human and veterinary medicine].
    Dodet B, Heseltine E, Mary C, Saliou P.
    Sante; 1997 May 29; 7(3):195-9. PubMed ID: 9296811
    [Abstract] [Full Text] [Related]

  • 7. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.
    J Infect Dis; 2006 Aug 01; 194(3):370-6. PubMed ID: 16826486
    [Abstract] [Full Text] [Related]

  • 8. Rotavirus vaccines: targeting the developing world.
    Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [Abstract] [Full Text] [Related]

  • 9. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec 01; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 10. Rotavirus vaccines--an update.
    Dennehy PH.
    Vaccine; 2007 Apr 20; 25(16):3137-41. PubMed ID: 17321017
    [Abstract] [Full Text] [Related]

  • 11. [Development of a rotavirus vaccine. Field trials in Venezuela].
    Pérez Schael I, Rojas Mazzei AM, Flores J.
    Acta Cient Venez; 1991 Apr 20; 42(6):296-312. PubMed ID: 1668865
    [Abstract] [Full Text] [Related]

  • 12. The current status of diarrhoea related vaccines.
    Sarkar SK, Pal SC.
    Indian J Public Health; 1990 Apr 20; 34(1):20-34. PubMed ID: 1966245
    [Abstract] [Full Text] [Related]

  • 13. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O, Cunliffe NA.
    Curr Opin Infect Dis; 2007 Oct 20; 20(5):501-7. PubMed ID: 17762784
    [Abstract] [Full Text] [Related]

  • 14. Development of candidate rotavirus vaccines derived from neonatal strains in India.
    Glass RI, Bhan MK, Ray P, Bahl R, Parashar UD, Greenberg H, Rao CD, Bhandari N, Maldonado Y, Ward RL, Bernstein DI, Gentsch JR.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S30-5. PubMed ID: 16088802
    [Abstract] [Full Text] [Related]

  • 15. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ.
    Am J Dis Child; 1990 Mar 01; 144(3):285-9. PubMed ID: 2154925
    [Abstract] [Full Text] [Related]

  • 16. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF, Offit PA, Plotkin SA, Heaton PM.
    Pediatr Infect Dis J; 2006 Jul 01; 25(7):577-83. PubMed ID: 16804425
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G, Ferrarini G, Rigolin F, Bogaerts H, André FE.
    Helv Paediatr Acta; 1986 Aug 01; 41(3):203-8. PubMed ID: 3019954
    [Abstract] [Full Text] [Related]

  • 20. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y, Kapikian AZ.
    J Health Popul Nutr; 2000 Jun 01; 18(1):5-14. PubMed ID: 11014764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.